Rollins Downgraded After Second EPS Miss in Four Quarters
Rollins reported Q2 2026 EPS of $0.32, missing the $0.34 consensus by 5.9%, its second miss in four quarters, which triggered a 15% sell-off and an Argus Research downgrade to Hold. At 28x forward ear
Argus Cuts Rollins to Hold After Q2 Miss, 15% Drop
NEW YORK, August 6 —
Rollins, Inc. (ROL) delivered a second EPS miss in four quarters when it reported Q2 2026 results on July 22, triggering a 15% six-day sell-off and an Argus Research downgrade to Hold. The pest-control company now trades at 28x forward earnings, roughly $8.79 below the analyst consensus price target.
- Q2 2026 EPS of $0.32 missed the $0.34 consensus by 5.9%; Argus downgraded to Hold.
- Trailing revenue $3.92B growing 7.9% year over year, 52.4% gross margins, $502M in annual free cash flow.
The Consecutive Miss Problem
Rollins has now missed EPS estimates in two of its last four quarters. The Q2 2026 filing shows $0.32 against a $0.34 consensus, modest in isolation but landing at 28.0x forward earnings on a $17.70 billion market cap, a multiple that tolerates no slippage. Argus Research downgraded to Hold, and SimplyWallSt argued ROL "looks rich even after a 35% drop." The sell-off has not reset expectations to match the execution record.
What Pest Control Actually Earns
Atlanta-based Rollins provides residential and commercial pest control, covering rodents, insects, wildlife, and termites, alongside workplace programs for healthcare, food service, and logistics clients where infestations carry regulatory consequences. The business generated trailing revenue of $3.92 billion growing 7.9%, a 52.4% gross margin, and $502 million in annual free cash flow. A DCF analysis tied to that cash flow needs sustained growth to justify the multiple; two of the last four quarters suggest growth is stalling. Insiders hold 38.4% of shares, which limits institutional exits but makes any further decline personally costly for executives.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| ROL | $17.7B | 28.2x | -34.7% |
| IEX | $17.2B | 24.6x | +46.8% |
| JKHY | $11.2B | 22.1x | -4.6% |
| ALLE | $14.3B | 17.4x | -1.5% |
| MTD | $28.5B | 27.5x | +16.8% |
| VRSK | $24.9B | 21.8x | -27.0% |
The CFO's Underwater Grant
The sharper signal involves Rollins's newest executive. The bear case: erratic execution at a demanding multiple. Strong free cash flow and 38.4% insider ownership limit how far shares can fall. The number that flips the thesis: Q3 2026 EPS meeting or beating consensus. A third miss forces a re-rating. Run the free Rollins, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why did Rollins stock drop 15%?
Rollins reported Q2 2026 EPS of $0.32, missing the consensus estimate of $0.34 by 5.9%, its second miss in four quarters. The results, released July 22, triggered a 15% sell-off over six trading days and prompted Argus Research to downgrade the stock to Hold.
What multiple does Rollins trade at after the sell-off?
After the sell-off, Rollins trades at 28x forward earnings on a market cap of $17.70 billion, with shares at $36.795. That price sits $8.79 below the analyst consensus target of $45.59, a target assembled before this miss registered.
What did Argus Research say about Rollins?
Argus Research downgraded Rollins to Hold following the Q2 2026 EPS miss. SimplyWallSt separately argued that Rollins looks rich even after a 35% drop, suggesting the sell-off had not reset expectations to match the company's execution record.
Is the new Rollins CFO's equity grant underwater?
William Wayne Harkins II, appointed CFO per an 8-K filed May 27, 2026, received an equity grant of 11,866 shares at $42.14 on July 1, three weeks before Q2 results were released. At the current share price of $36.795, those shares sit $5.35 each below the grant price.
What would flip the Rollins investment thesis?
The article identifies Q3 2026 EPS meeting or beating consensus as the single number that would flip the thesis. A third miss would force a re-rating, while $502 million in annual free cash flow and 38.4% insider ownership are cited as limits on the downside.
Rollins, Inc. delivered a second EPS miss in four quarters when it reported Q2 2026 results on July 22, sparking a 15% six-day sell-off and an Argus Research downgrade to Hold — yet the stock now sits roughly $8.79 below the analyst consensus target, leaving investors to judge whether a resilient, cash-generative pest-control business has finally become cheap or merely less expensive.